Related by context. All words. (Click for frequent words.) 72 huC# DM4 72 oral prodrug 72 SAR# [004] 72 alvespimycin 71 SAR# [002] 70 mertansine 68 FOLOTYN ® 68 Dapagliflozin 68 interferon gamma 1b 68 trastuzumab DM1 68 virus HCV protease inhibitor 68 YONDELIS 68 PEGylated anti 68 TNF Tumor Necrosis Factor 68 mapatumumab 68 Zolinza 68 phase III isavuconazole 68 HuMax EGFr 68 non nucleoside inhibitor 68 MKC# MT 68 ZOLINZA 68 Parkinson disease levodopa induced 68 Abiraterone acetate 68 Tezampanel 68 docetaxel Taxotere ® 67 evaluating tivozanib 67 Azacitidine 67 TELINTRA 67 Mipomersen 67 Sym# 67 LY# [003] 67 JAK inhibitor 67 Safinamide 67 INCB# [003] 67 CDK inhibitor 67 ocular formulation 67 elotuzumab 67 Methylnaltrexone 67 PDE4 inhibitor 67 PEG SN# 67 Dasatinib 67 dyskinesia PD LID 67 allosteric modulator NAM 67 investigational monoclonal antibody 67 CYT# potent vascular disrupting 67 refractory chronic lymphocytic 67 orally administered inhibitor 67 erlotinib Tarceva ® 67 pertuzumab 67 PKC# 67 pan HDAC inhibitor 67 AEG# 67 thalidomide Thalomid 67 HGS ETR1 67 MAGE A3 ASCI 66 trastuzumab DM1 T DM1 66 INCB# [001] 66 Romidepsin 66 NVA# 66 IL# PE#QQR 66 sorafenib tablets 66 trastuzumab Herceptin R 66 phase IIb clinical 66 mGluR5 negative 66 investigational humanized monoclonal antibody 66 nucleoside analog 66 tenofovir Viread 66 novel VDA molecule 66 Sapacitabine 66 selective androgen receptor modulator 66 Seliciclib 66 cetuximab Erbitux 66 selective modulator 66 Amrubicin 66 Vidaza R 66 docetaxel Taxotere R 66 sorafenib Nexavar 66 mGluR5 NAM 66 Archexin 66 CR# vcMMAE 66 Pimavanserin 66 Vidaza azacitidine 66 SinuNase TM 66 Milatuzumab 66 Aflibercept 66 IAP inhibitor 66 Squalamine 66 ritonavir boosted 66 receptor tyrosine kinase inhibitor 66 generation Hsp# inhibitor 66 octreotide implant 66 Iloperidone 66 lanreotide 66 ABILIFY ® 65 Laquinimod 65 ganetespib 65 Pegasys ® 65 HGS ETR2 65 generation purine nucleoside 65 anakinra 65 Personalized Immunotherapy 65 TACI Ig 65 albiglutide 65 TYZEKA 65 BAY #-# 65 neratinib 65 Taxotere docetaxel 65 ocrelizumab 65 PSN# [002] 65 liposomal formulation 65 entinostat 65 metaglidasen 65 Insegia 65 midstage clinical 65 Tolvaptan 65 Phase Ib clinical trials 65 Elvitegravir 65 proteasome inhibitor 65 Panzem R NCD 65 Aviptadil 65 Ocrelizumab 65 riociguat 65 Tarceva TM 65 Vaprisol 65 Lenocta 65 NS#/#A protease 65 methylnaltrexone bromide 65 CEQ# 65 #D#C# 65 KRN# 65 CD# monoclonal antibody 65 Golimumab 65 Traficet EN 65 eltrombopag 65 long acting muscarinic 65 intranasal formulation 65 Panzem R 65 antibody MAb 65 pegylated interferon alfa 2a 65 myelofibrosis polycythemia vera 65 CD# CEA 65 highly selective inhibitor 65 Azedra 65 Bortezomib 65 HuMax CD4 65 acyclovir Lauriad R 65 histone deacetylase inhibitor 65 GW# [003] 65 CCR5 antagonist 65 Cleviprex TM clevidipine 65 polymerase inhibitor 65 DU #b 65 R#/MEM # 65 Luteinizing Hormone Releasing Hormone 65 histone deacetylase HDAC inhibitor 65 Eltrombopag 65 peripherally acting 65 Pafuramidine 65 lintuzumab SGN 65 systemically administered 65 Vorinostat 65 Hsp# Inhibitor 65 SARMs 65 Phase 2b Clinical Trial 65 IMC A# 65 Orally administered 65 dihydrochloride Tablets 65 GTC recombinant human 65 tiapamil 65 dextromethorphan quinidine 65 Civacir 65 angiogenesis inhibitor 65 Cetrorelix 65 nelfinavir 65 RhuDex ® 65 IAP inhibitors 65 severe hypercholesterolemia 65 FUSILEV ® 64 hormone LHRH antagonist 64 IMiDs ® 64 administered subcutaneously 64 Carfilzomib 64 aleglitazar 64 ospemifene 64 LibiGel ® 64 octreotide acetate 64 CDP# 64 dihydrochloride 64 pegylated interferons 64 Daclizumab 64 Ecallantide 64 Elotuzumab 64 Ceflatonin 64 microtubule inhibitor 64 DDP# 64 rNAPc2 64 MEK inhibitor 64 PDX pralatrexate 64 SERMs 64 TRO# 64 PHX# 64 panitumumab Vectibix 64 vinca alkaloid 64 Onconase 64 TLK# 64 orally bioavailable 64 baminercept 64 investigational antiplatelet agent 64 bevacizumab Avastin ® 64 volociximab 64 nucleoside analogues 64 Alocrest 64 OMP #M# 64 Nexavar ® 64 alfa 2a 64 YONDELIS R 64 Epivir 64 posaconazole 64 alefacept 64 non nucleoside HCV 64 CCX# 64 ACTEMRA TM 64 ergot derivatives 64 lapatinib Tykerb 64 CYC# 64 2 methoxyestradiol 64 Elesclomol 64 Ophena TM 64 Boceprevir 64 Cloretazine 64 Clolar ® 64 Sodium oxybate 64 Phase IIb clinical trials 64 Tyrima 64 FOLFOX6 chemotherapy regimen 64 oral salmon calcitonin 64 PRT# 64 Akt inhibitor 64 PROMACTA 64 inhibitor RG# 64 Milnacipran 64 sitaxsentan 64 Pemetrexed 64 Bevacizumab 64 Vandetanib 64 class mGluR5 inhibitor 64 SNT MC# 64 induced macular edema 64 Genentech Rituxan 64 rasagiline tablets 64 TRANSDUR Sufentanil 64 Cloretazine ® 64 small molecule thrombopoietin 64 weekly subcutaneous injections 64 Pivotal Phase III 64 Randomized Double blind 64 Contrave# 64 IMiDs R 64 Aplidin 64 HGS ETR1 mapatumumab 64 subcutaneous formulation 64 Adenoscan R 64 favorable pharmacokinetic profile 64 Lu AA# 64 Leukine ® 64 dopamine receptor agonist 64 Teriflunomide 64 Tanespimycin 64 RELOVAIR ™ 64 Fludara ® 64 VEGF inhibitors 64 GSK# [002] 64 Xelox 64 ADP receptor antagonist 64 esomeprazole Nexium 64 R#/MEM 64 Copegus ribavirin 64 MDV# 64 forodesine 64 midstage trials 64 Nanobody 64 PSMA ADC 64 Presents Preclinical 64 Kuvan sapropterin dihydrochloride 64 EndoTAG TM -1 64 diabetic neuropathic pain 64 TBC# 64 PEG Interferon lambda 64 cysteamine bitartrate 64 fosbretabulin 64 RGB # 64 Crizotinib 64 refractory gout 64 combines bupropion 64 Tocilizumab 64 phase IIb 63 adalimumab Humira 63 Bezielle 63 Phase Ib study 63 Cancidas 63 alpha 2a 63 vemurafenib 63 MyVax R 63 Proellex TM 63 Rebif ® 63 GSK# [001] 63 BRAF inhibitor 63 cannabinor 63 radezolid 63 mesylate 63 TMC# [002] 63 LAF# 63 Pralatrexate 63 Investigational Compound 63 oxaliplatin Eloxatin 63 Anidulafungin 63 GAMMAGARD 63 lumiliximab 63 peptidic compound 63 NV1FGF 63 Alinia 63 cilengitide 63 Silodosin 63 canagliflozin 63 Olaparib 63 antibody MT# 63 teduglutide 63 Tasimelteon 63 novel peptide 63 Sustiva efavirenz 63 humanized anti 63 Aurexis 63 CORT # 63 oral proteasome inhibitor 63 candesartan cilexetil 63 Trastuzumab DM1 63 amprenavir 63 potent CYP#A# inhibitors 63 TELCYTA 63 arsenic trioxide injection 63 small molecule Hedgehog 63 Capesaris 63 NXL# 63 INSPIRE Trial Phase III 63 HGS# 63 Phase 1b trial 63 R Saizen R 63 S/GSK# 63 axitinib 63 Onalta 63 pomalidomide 63 mitogen activated ERK kinase 63 ELACYT 63 metastatic castration resistant 63 Darusentan 63 intravenous acetaminophen 63 midstage clinical trials 63 phase IIb study 63 nucleotide analogue 63 Arimoclomol 63 EOquin TM 63 Muraglitazar 63 galiximab 63 Diamyd ® 63 relapsed leukemia 63 Tesetaxel 63 Telik logo TELINTRA 63 Zalbin 63 Aclidinium 63 bortezomib Velcade 63 decitabine 63 Zenvia ™ 63 sodium thiosulfate STS 63 OMNARIS HFA 63 BCX# 63 R sorafenib tablets 63 ASONEP 63 retapamulin 63 Eraxis 63 Radezolid 63 Taxol paclitaxel 63 GAP #B# 63 KNS # 63 Proxinium TM 63 phase IIb trial 63 eliglustat tartrate 63 aripiprazole Abilify 63 peginterferon alpha 2a 63 oral dual endothelin 63 BARACLUDE R 63 ZK EPO 63 MNTX 63 radiolabeled TM# 63 HCV NS5B polymerase 63 Ixempra 63 huN# DM1 63 COPEGUS 63 Phase III Clinical Trial 63 pegylated 63 Omacetaxine 63 Aliskiren 63 HCV protease inhibitor 63 cetuximab Erbitux ® 63 Epratuzumab 63 Interferon Beta 63 Nasdaq HALO 63 Meets Primary Endpoint 63 adenosine injection 63 Romiplostim 63 Pharmacokinetics PK 63 DXL# 63 Zybrestat 63 TOCOSOL Camptothecin 63 telaprevir VX 63 acetonide FA 63 Enzastaurin 63 targeted radiotherapeutic 63 LymphoStat B belimumab 63 investigational protease inhibitor 63 Granulocyte Colony Stimulating Factor 63 dasatinib Sprycel ® 63 non nucleoside 63 calcineurin inhibitor 63 sodium glucose cotransporter 63 Randomized Phase 63 teriflunomide 63 Solazed TM 63 ELND# 63 HCV protease inhibitors 63 Oral NKTR 63 HQK 63 Reverset 63 cetuximab Erbitux R 63 FK# 63 alpha interferons 63 adipiplon 63 PXD# 63 motesanib 63 PF # [002] 63 pharmacodynamic properties 63 Herceptin trastuzumab 63 oral rivaroxaban 63 Xanafide 63 Sitagliptin 63 SCH # 63 Ozarelix 63 phase IIa 63 BZL# 63 Gilead Viread 63 Toremifene 63 SinuNase ™ 63 Jevtana 63 AAG geldanamycin analog 63 Peginterferon alfa 2b 63 hyperphenylalaninemia HPA due 63 Zorbtive TM 63 mecamylamine 63 OXi# 63 ENMD # 63 SRT# [003] 63 Xcytrin R 63 ALN HPN 63 GLYX 63 5 HT6 receptor 63 Nexavar sorafenib 63 PNP inhibitor 63 idarubicin 63 non peptidic protease 63 beta 1a 63 rifabutin 63 multitargeted 63 IMA# 63 CD# antibody [001] 63 JAK2 inhibitor 63 oral ridaforolimus 63 tenofovir emtricitabine 63 GRN# 63 cediranib 63 Avastin bevacizumab 63 Vicriviroc 63 Elagolix 63 MT#/MEDI-# 63 Pertuzumab 63 Adalimumab 63 outlicensed 63 Phase Ib clinical 63 Novolimus 62 LEVADEX ™ 62 preclinical pharmacokinetic 62 Sebivo 62 ATL# [001] 62 SNRI 62 methylnaltrexone 62 Chemophase 62 PD LID 62 efalizumab 62 Annamycin 62 TKM ApoB 62 visilizumab 62 NP2 Enkephalin 62 Lubiprostone 62 ORENCIA R 62 Eculizumab 62 Ropinirole 62 Inhalation Aerosol 62 zileuton 62 LymphoStat B TM 62 goserelin 62 multicenter Phase II 62 investigational pan BCR 62 pimozide 62 Afatinib 62 iniparib 62 5 FU leucovorin 62 Phase IIb Trial 62 Well Tolerated 62 pralatrexate injection folate analogue 62 Tracleer R 62 Triolex 62 tezampanel 62 CTAP# Capsules 62 tolvaptan 62 gabapentin enacarbil 62 AEGR 62 LymphoStat B 62 rilonacept 62 cancer immunotherapies 62 PI3K/Akt pathway inhibitor 62 Spiegelmer ® 62 compound INCB# 62 Aztreonam lysine 62 Leukine 62 TRANSDUR ® 62 Zemiva TM 62 pharmacokinetic PK study 62 SILENOR 62 polymerase inhibitors 62 vascular disrupting agent 62 Gemzar ® 62 Celebrex celecoxib 62 Saxagliptin 62 Aryplase 62 CYP#A# CYP#D# 62 Initiates Enrollment 62 HSP# inhibitor 62 pioglitazone HCl 62 Ambrisentan 62 RhuDex 62 BRILINTA 62 TRACON Pharmaceuticals 62 anticancer compound 62 Clevudine 62 MCSP respectively 62 lixisenatide 62 selective kinase inhibitor 62 Palifosfamide 62 Telavancin 62 LEXIVA r 62 selective estrogen receptor modulator 62 Kahalalide F 62 targeting CD# 62 developing Bicifadine serotonin 62 Liprotamase 62 6R BH4 62 phase Ib clinical 62 telomerase therapeutic 62 R lenalidomide 62 Dalbavancin 62 LEP ETU 62 Serostim ® 62 ulimorelin 62 protein tyrosine phosphatase 1B 62 Copegus R 62 CANCIDAS 62 Ixabepilone 62 lenalidomide Revlimid R 62 Initiate Phase 62 tafamidis 62 ALN PCS 62 Zenvia TM 62 MYCAMINE 62 Linagliptin 62 albinterferon alfa 2b 62 sitagliptin 62 L BLP# 62 Roche Xeloda 62 Pazopanib 62 demonstrated antitumor activity 62 Decitabine 62 Ridaforolimus 62 rituximab Rituxan 62 darapladib 62 atrasentan 62 Mg Usa 62 bevacizumab Avastin 62 OHR/AVR# 62 Omnitarg 62 MEK Inhibitor 62 etanercept Enbrel 62 GVAX ® 62 dexamethasone Decadron 62 SNALP technology 62 OMP #R# 62 class anticancer quinolone 62 Recombinant Human 62 inhaled formulation 62 Cannabinor 62 alvimopan 62 delafloxacin 62 Zarnestra 62 Cethromycin 62 AZT zidovudine Retrovir 62 multi kinase inhibitor 62 Roche Chugai s 62 Vidaza ® 62 bicifadine 62 Panzem 62 delivers fluocinolone acetonide FA 62 MEK inhibitors 62 Excellarate TM 62 #th Annual Interscience 62 macrolide antibiotic 62 ZADAXIN ® 62 HuLuc# 62 Darinaparsin 62 PORxin TM platforms 62 Remicade infliximab 62 VEGFR2 inhibitor 62 oral methylnaltrexone 62 Vicinium TM 62 CTA# Injection 62 Friedreich Ataxia FRDA 62 Melphalan 62 MKC# MKC# PP 62 maleate 62 MGCD# [001] 62 iobenguane 62 mocetinostat 62 IgG1 monoclonal antibody 62 sunitinib Sutent ® 62 IMiDs ® compound 62 Completes Patient Enrollment 62 ALN TTR 62 PEGylated Fab fragment 62 thymalfasin 62 dependent kinase inhibitor 62 DermaVir Patch 62 talactoferrin 62 hyaluronidase enzyme 62 oral taxane 62 SELZENTRY 62 Panzem NCD 62 lesinurad 62 VAPRISOL 62 monoclonal antibody conjugated 62 lamotrigine Lamictal 62 Proquin XR 62 urocortin 2 62 substrates inhibitors 62 protein kinase inhibitor 62 preclinical efficacy 62 Voreloxin 62 ESBA# 62 MTP inhibitor 62 Lacosamide 62 Pirfenidone 62 CRLX# 62 interferon IFN 62 zanolimumab 62 alkylating agent 62 plus Copegus R 62 Ampligen R 62 GRNVAC1 62 TRAIL receptor antibodies 62 cell lymphoma CTCL 62 daclizumab 62 febuxostat 62 EOquin 62 Naproxcinod 62 deforolimus 62 Xeloda ® 62 EVIZON TM 62 sapropterin dihydrochloride Tablets 62 rivastigmine Exelon 62 Campath ® 62 PREZISTA r 62 calcitonin 62 Raptiva ® 62 Azixa 62 teplizumab 62 EXPAREL TM 62 luteinizing hormone releasing 62 adecatumumab MT# 62 PEGylated 62 mGluR2 positive 62 docetaxel chemotherapy 62 Femara letrozole 62 Refractory Hodgkin Lymphoma 62 Thiovir 62 MYDICAR ® 62 prokinetic agent 62 Phase #b/#a clinical 62 Imetelstat 62 tubulin inhibitor 62 BIM #A# 62 REVLIMID lenalidomide 62 anidulafungin 62 Atripla combines 62 lomitapide 62 cromolyn sodium 62 RhuDex R 62 investigational hepatitis C 62 sulindac 62 metformin sulfonylurea 62 NGX# 61 Navelbine ® 61 vapreotide acetate 61 APTIVUS 61 TLR9 agonist 61 Rivaroxaban 61 diarrhea predominant irritable 61 romiplostim 61 receptor partial agonist 61 selective A2A adenosine receptor 61 Luveris R Ovidrel R 61 urate lowering 61 abacavir lamivudine 61 Cimzia ® certolizumab pegol 61 NMDA antagonist 61 eprotirome 61 rilpivirine 61 Initiates Phase III 61 itraconazole Sporanox 61 velafermin 61 temsirolimus 61 Zoloft sertraline 61 #I TM# 61 modulator SERM 61 latrepirdine 61 safinamide 61 pegylated liposomal doxorubicin 61 BRIM3 61 Intravenous Human 61 Achieves Primary Endpoint 61 corticosteroid dexamethasone 61 XL# anticancer compounds 61 trastuzumab Herceptin 61 LB# [003] 61 Tibotec Therapeutics division 61 Phase 2a trial 61 Piperacillin 61 sorafenib Nexavar R 61 danoprevir 61 aflibercept VEGF Trap 61 Interferon beta 1a 61 Nitazoxanide 61 Omacetaxine mepesuccinate 61 ZEVALIN ® 61 Raltegravir 61 Vitaxin 61 Initiate Clinical Trial 61 CYT# QbG# 61 flutamide 61 ascending dose 61 indacaterol 61 leflunomide 61 PegIntron 61 BrachySil 61 PEGINTRON TM 61 infliximab Remicade 61 Irinotecan 61 CIMZIA TM 61 ISTODAX 61 Gel repository corticotropin injection 61 ara C 61 nalbuphine ER 61 REP# 61 Revlimid lenalidomide 61 Factor VIIa 61 DEB# 61 Exherin TM 61 Clinical Trial Results 61 pharmacologically active isomer 61 Quinamed 61 ZACTIMA 61 metastatic castrate resistant 61 AZILECT R 61 Vernakalant 61 squalamine 61 esophageal candidiasis 61 Neulasta ® 61 maximally tolerated dose 61 Pancreas Cancer Vaccine 61 COREG CR 61 tanespimycin 61 Viprovex TM 61 somatostatin analogue 61 Actemra tocilizumab 61 RSD# 61 interleukin IL -# 61 Denufosol 61 Blinatumomab 61 tenofovir disoproxil fumarate 61 MGd 61 ONGLYZA ™ 61 bazedoxifene conjugated estrogens 61 evaluating satraplatin 61 Tolerability 61 Telmisartan 61 novel anticancer 61 dexpramipexole 61 evaluating picoplatin 61 Canvaxin 61 oral antiviral 61 pharmacokinetic interactions 61 PRX # 61 Vitrasert R 61 Gleevec imatinib mesylate 61 Zoraxel 61 Nanobody ® 61 DAVANAT 61 serotonin norepinephrine reuptake inhibitor 61 treat benign prostatic 61 Pegloticase 61 MOZOBIL 61 PI3K inhibitor 61 CD3 monoclonal antibody 61 Edurant 61 Calcitonin 61 Relivar 61 ® lenalidomide 61 vaccine GRNVAC1 61 JAK2 Inhibitor 61 highly purified pasteurized 61 Tipranavir 61 Curaxin CBLC# 61 FOLFOX chemotherapy 61 tyrosine kinase inhibitor 61 indinavir Crixivan 61 TRANSDUR ™ 61 pharmacokinetic equivalence 61 Angiocept 61 lucinactant 61 Targretin 61 Paxil paroxetine 61 Adentri 61 chimeric monoclonal antibody 61 investigational compounds 61 lexidronam injection 61 Deferiprone 61 TO AVOID PREGNANCY WHILE 61 nilotinib Tasigna 61 Aurora kinase inhibitor 61 Glatiramer Acetate 61 anti CD3 antibody 61 Myocet 61 REGN# 61 Febuxostat 61 IRX 2 61 relapsed MM 61 tiuxetan 61 Sudhir Agrawal D.Phil 61 CA4P 61 AZILECT ® 61 Pruvel 61 anti TNF alpha 61 Temsirolimus 61 Phase III Clinical Trials 61 oral Janus kinase 61 polysaccharide polymer 61 including eniluracil ADH 61 veltuzumab 61 Dabigatran etexilate 61 MYDICAR 61 aerosolized AAT 61 QNEXA ® 61 Phase III Trial 61 Trastuzumab 61 Novel Oral 61 vidofludimus 61 peginesatide 61 rxRNA 61 PNT# 61 tezampanel NGX# 61 IMiDs 61 gamma secretase inhibitor 61 Inhalation Solution 61 Mg Uk 61 RoACTEMRA 61 Rasagiline 61 paclitaxel Taxol 61 Reports Preclinical Data 61 selective S#P# receptor agonist 61 tinidazole 61 topically applied SEPA 61 antifungal agent 61 Rotigotine 61 5 fluorouracil leucovorin 61 systemic RNAi therapeutic 61 oral deforolimus 61 insulin glulisine 61 Sanofi Aventis Taxotere 61 bexarotene 61 ThGRF 61 acting muscarinic antagonist 61 Nasdaq PARD 61 sulfonylhydrazine class 61 regadenoson 61 pralatrexate 61 cathepsin K inhibitor 61 refractory acute myeloid 61 BiovaxID TM 61 severe gastroparesis 61 Pathway Inhibitor 61 liposome injection 61 Ganciclovir 61 primary hypercholesterolemia 61 DURIN TM 61 LY# [002] 61 GnRH antagonist 61 Besivance 61 Corlux 61 AQD class 61 ELADUR ™ 61 Cimzia certolizumab pegol 61 basal bolus regimen 61 omega interferon 61 p# inhibitor 61 XP# XP# 61 signal transduction inhibitor 61 torezolid phosphate 61 carcinoid syndrome 61 Albuferon TM 61 Survivin antagonist 61 ATL# [002] 61 Cloretazine VNP#M 61 Bicifadine 61 T#I [002] 61 Valopicitabine 61 phase Ib 61 NU# direct 61 superficial bladder cancer 61 REYATAZ R 61 taxane resistant 61 Arranon 61 GATTEX TM 61 Phase Ib II 61 bortezomib Velcade ® 61 Solazed ™ 61 lintuzumab 61 custirsen 61 ongoing Phase 1b 61 eniluracil 61 Moxifloxacin 61 Zoledronic acid 61 anti HAAH antibodies 61 CCX# B 61 Belimumab 61 Anti VEGF 61 Exelixis compounds 61 ixabepilone 61 VELCADE melphalan 61 Androxal TM 61 Viread Emtriva 61 AVASTIN 61 nucleoside reverse transcriptase inhibitor 61 Kosan dependence 61 metastatic hormone refractory 61 TPI ASM8 61 Tocosol Paclitaxel 61 ThermoDox R 61 solanezumab 61 administered concomitantly 61 NS5B polymerase 61 Phase IIa trials 61 CCR5 inhibitor 61 Zavesca R 61 MIRCERA 61 humanized therapeutic 61 relapsed multiple myeloma 61 PRISTIQ 61 hypereosinophilic syndrome 61 Onalta ™ 61 hypoxia activated prodrug 61 Aurora kinase 61 PrevOnco 61 Neupro R 61 ARIKACE 61 COLAZAL R 61 Prosaptide 61 recurrent metastatic ovarian cancer 61 pemetrexed Alimta 61 tenofovir DF 61 Icatibant 61 HCD# [002] 61 MAXY alpha 61 IXEMPRA 61 rabeprazole 61 Glufosfamide